跳至主要内容
临床试验/ITMCTR2100004240
ITMCTR2100004240
尚未招募
未知

Multicenter randomized controlled clinical trial of Tailin formulation combined with prolonged, low-dose antimicrobial therapy for recurrent urinary tract infection

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
recurrent urinary tract infection
发起方
Shanghai Municipal Hospital of Traditional Chinese Medicine
状态
尚未招募
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional study
性别
All

研究者

入排标准

入选标准

  • 1\. In line with the RUTI diagnostic criteria of Western medicine;
  • 2\. In line with the diagnostic criteria of traditional Chinese medicine;
  • 3\. between the ages of 18 and 75;
  • 4\. Voluntarily accept treatment and sign informed consent.

排除标准

  • 1\. The first episode of acute urinary tract infection;
  • 2\. Imaging examination found urinary tract congenital malformation, renal pelvis stones and other lesions;
  • 3\. Urinary tract syndrome;
  • 4\. Patients with stage 4\-5 chronic kidney disease (CKD) (i.e. EGFR \<30ml/min);
  • 5\. Patients with severe heart, liver function damage or diabetes need immediate treatment;
  • 6\. Patients who are allergic to two antibiotics in the antimicrobial therapy in this experiment;
  • 7\. Pregnant or nursing women (women of childbearing age need to do urine HCG test to determine whether there is pregnancy);
  • 8\. Severe central nervous system diseases;
  • 9\. Drugs within 3 months.

结局指标

主要结局

未指定

相似试验